1 completed. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Completed 1 |
Follow relebactam: new trials by email Literature Review of relebactam trials Research Report on relebactam
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Imipenem/Relebactam/Cilastatin Versus Piperacillin/Tazobactam for Treatment of Participants With Bacterial Pneumonia (MK-7655A-014) Imipenem, Relebactam, Cilastatin - Bacterial Pneumonia | Phase 3 | Completed | Merck Sharp & Dohme LLC | 537 | 2015-11-24 | 2020-04-16 |
PMID 32785589, PMID 34704389, PMID 37383243, PMID 41586496, PMID 42743113
2015 (1)